Nutriband Inc. to Showcase Innovations at Noble Capital Markets Emerging Growth Virtual Conference

Nutriband Inc. (NASDAQ: NTRB), a leader in the development of transdermal pharmaceutical products, announced its participation in the Noble Capital Markets Emerging Growth Virtual Equity Conference. CEO Gareth Sheridan will lead a fireside chat, offering insights into the company's innovative AVERSA(TM) technology, designed to combat drug abuse and misuse. This presentation underscores Nutriband's commitment to addressing the global opioid crisis through technological innovation.

The significance of Nutriband's presentation lies in the potential of its AVERSA technology to revolutionize the pharmaceutical industry. By integrating this technology into transdermal patches, Nutriband aims to prevent the abuse, misuse, and accidental exposure of drugs with high abuse potential, such as fentanyl. This development is particularly relevant in the current climate, where the opioid epidemic continues to pose significant public health challenges worldwide.

Investors and industry stakeholders will have the opportunity to engage with Nutriband's leadership during the conference, gaining valuable insights into the company's strategic direction and the broader implications of its technology for the pharmaceutical sector. The availability of the presentation webcast post-event ensures wider accessibility, allowing a broader audience to understand the importance of Nutriband's work in combating drug abuse.

Nutriband's participation in this conference not only highlights its innovative approach to pharmaceutical development but also signals the growing importance of abuse-deterrent technologies in the fight against the opioid crisis. As the company continues to advance its product portfolio, its efforts could have far-reaching impacts on public health, offering safer alternatives for pain management and reducing the potential for drug abuse.